Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
19 Sep 2024 |
AP01 |
Appointment of Khalid El Ansari as a director on 10 September 2024
|
|
|
18 Sep 2024 |
TM01 |
Termination of appointment of Mariano Jesus Godino Escolar as a director on 9 September 2024
|
|
|
22 Aug 2024 |
AA |
Full accounts made up to 31 December 2023
|
|
|
13 May 2024 |
CS01 |
Confirmation statement made on 8 May 2024 with updates
|
|
|
03 Oct 2023 |
AA |
Full accounts made up to 31 December 2022
|
|
|
05 Jun 2023 |
CH02 |
Director's details changed for Haleon Uk Corporate Director Limited on 18 July 2022
|
|
|
25 May 2023 |
CS01 |
Confirmation statement made on 8 May 2023 with updates
|
|
|
24 May 2023 |
PSC05 |
Change of details for Glaxosmithkline Consumer Healthcare (Overseas) Limited as a person with significant control on 18 November 2022
|
|
|
23 May 2023 |
AD02 |
Register inspection address has been changed from 980 Great West Road Brentford Middlesex TW8 9GS United Kingdom to Building 5 First Floor the Heights Weybridge Surrey KT13 0NY
|
|
|
17 May 2023 |
CH02 |
Director's details changed for Gsk Consumer Healthcare Holdings No.4 Limited on 31 March 2023
|
|
|
03 Oct 2022 |
AA |
Full accounts made up to 31 December 2021
|
|
|
15 Aug 2022 |
CH01 |
Director's details changed for Mr Scott Christopher Bourgeois on 30 June 2022
|
|
|
22 Jul 2022 |
CERTNM |
Company name changed prism pch LIMITED\certificate issued on 22/07/22
-
NM01 ‐
Change of name by resolution
-
RES15 ‐
Change company name resolution on 2022-07-21
|
|
|
18 Jul 2022 |
AD01 |
Registered office address changed from 980 Great West Road Brentford TW8 9GS England to Building 5, First Floor the Heights Weybridge Surrey KT13 0NY on 18 July 2022
|
|
|
13 Jun 2022 |
AP01 |
Appointment of Mr Scott Christopher Bourgeois as a director on 6 June 2022
|
|
|
07 Jun 2022 |
TM01 |
Termination of appointment of Nicholas Ian Cooper as a director on 6 June 2022
|
|
|
24 May 2022 |
CS01 |
Confirmation statement made on 12 May 2022 with updates
|
|
|
06 Apr 2022 |
TM01 |
Termination of appointment of Glaxo Group Limited as a director on 6 April 2022
|
|
|
06 Apr 2022 |
AP02 |
Appointment of Gsk Consumer Healthcare Holdings No.4 Limited as a director on 6 April 2022
|
|
|
31 Dec 2021 |
PSC02 |
Notification of Glaxosmithkline Consumer Healthcare (Overseas) Limited as a person with significant control on 9 December 2021
|
|
|
31 Dec 2021 |
PSC07 |
Cessation of Gsk Consumer Healthcare Holdings (No.1) Limited as a person with significant control on 9 December 2021
|
|
|
23 Dec 2021 |
AA |
Full accounts made up to 31 December 2020
|
|
|
08 Dec 2021 |
SH19 |
Statement of capital on 8 December 2021
|
|
|
08 Dec 2021 |
SH20 |
Statement by Directors
|
|
|
08 Dec 2021 |
CAP-SS |
Solvency Statement dated 07/12/21
|
|